Dr. Ira Longini and colleagues outline three methods for deploying vaccine trials in emergency situations.
Dr. Ira Longini and colleagues say there is a nearly 20 percent chance that isolated cases will likely make their way to the United States by the end of September.
Dr. Ira Longini, a professor in the department of biostatistics, has been named a Fellow of the American Association for the Advancement of Science, an honor bestowed upon AAAS members for their distinguished efforts to advance science or its applications.
Dr. Ira Longini is working to ensure humanity is ready for the debut of the next new infectious disease.
In a new study researchers explain how seasonal H1N1 influenza became resistant to the most widely used antiviral agent for treating and preventing flu.